血醣控制爭議

將HbA1c控制在6%以下，結果反而導致mortality增加

ACCORD trial

For Safety, NHLBI Changes Intensive Blood Sugar Treatment Strategy in Clinical Trial of Diabetes and Cardiovascular Disease
NIH press release

http://www.nhlbi.nih.gov/health/prof/heart/other/accord/remarks.pdf